Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Jamie Dimon warns Iran war could drive inflation, interest rates higher - 2Linda Hamilton, 69, says she doesn't want to 'chase longevity'
- 3Flying without a Real ID? That'll soon cost you $45, TSA says.
- 4Find the Future of Outsourcing: Exploring the Gig Economy
- 5First SpaceX booster for upgraded Starship fails during test in Texas
- The Response Uncovered: Disentangling the Secrets of the Universe
- The most effective method to Involve Handshakes for Compromise and Compromise
- Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
- Paris Agreement target off the table, report says
- Israel faces widespread condemnation as NGO ban comes into effect
- Israel strikes Beirut amid rocket fire from Hezbollah and Iran
- Opening Your True capacity: 12 Techniques for Personal growth
- 5 Home EV Chargers for Proficient and Solid Charging
- Congolese rape survivors search in vain for medicine after USAID cuts
